12. NAC.runipar (1999) Características Da DMD

9
See discussions, stats, and author profiles for this publication at: http://www.researchgate.net/publication/265844248 CARACTERÍSTICAS DA DISTROFIA MUSCULAR DE DUCHENNE ARTICLE · JANUARY 1999 CITATIONS 4 DOWNLOADS 7,641 VIEWS 167 1 AUTHOR: Fátima Aparecida Caromano University of São Paulo 84 PUBLICATIONS 65 CITATIONS SEE PROFILE Available from: Fátima Aparecida Caromano Retrieved on: 04 August 2015

description

distrofia muscular de duchenne

Transcript of 12. NAC.runipar (1999) Características Da DMD

Page 1: 12. NAC.runipar (1999) Características Da DMD

Seediscussions,stats,andauthorprofilesforthispublicationat:http://www.researchgate.net/publication/265844248

CARACTERÍSTICASDADISTROFIAMUSCULARDEDUCHENNE

ARTICLE·JANUARY1999

CITATIONS

4

DOWNLOADS

7,641

VIEWS

167

1AUTHOR:

FátimaAparecidaCaromano

UniversityofSãoPaulo

84PUBLICATIONS65CITATIONS

SEEPROFILE

Availablefrom:FátimaAparecidaCaromano

Retrievedon:04August2015

http://www.researchgate.net/publication/265844248_CARACTERSTICAS_DA_DISTROFIA_MUSCULAR_DE_DUCHENNE?enrichId=rgreq-49bfaf6b-7ec4-42cf-8a48-445cb5da46c5&enrichSource=Y292ZXJQYWdlOzI2NTg0NDI0ODtBUzoxNDMzMjE3MDM5MTU1MjBAMTQxMTE4MTk2NTkzMQ%3D%3D&el=1_x_2
http://www.researchgate.net/publication/265844248_CARACTERSTICAS_DA_DISTROFIA_MUSCULAR_DE_DUCHENNE?enrichId=rgreq-49bfaf6b-7ec4-42cf-8a48-445cb5da46c5&enrichSource=Y292ZXJQYWdlOzI2NTg0NDI0ODtBUzoxNDMzMjE3MDM5MTU1MjBAMTQxMTE4MTk2NTkzMQ%3D%3D&el=1_x_3
http://www.researchgate.net/?enrichId=rgreq-49bfaf6b-7ec4-42cf-8a48-445cb5da46c5&enrichSource=Y292ZXJQYWdlOzI2NTg0NDI0ODtBUzoxNDMzMjE3MDM5MTU1MjBAMTQxMTE4MTk2NTkzMQ%3D%3D&el=1_x_1
http://www.researchgate.net/profile/Fatima_Caromano?enrichId=rgreq-49bfaf6b-7ec4-42cf-8a48-445cb5da46c5&enrichSource=Y292ZXJQYWdlOzI2NTg0NDI0ODtBUzoxNDMzMjE3MDM5MTU1MjBAMTQxMTE4MTk2NTkzMQ%3D%3D&el=1_x_4
http://www.researchgate.net/profile/Fatima_Caromano?enrichId=rgreq-49bfaf6b-7ec4-42cf-8a48-445cb5da46c5&enrichSource=Y292ZXJQYWdlOzI2NTg0NDI0ODtBUzoxNDMzMjE3MDM5MTU1MjBAMTQxMTE4MTk2NTkzMQ%3D%3D&el=1_x_5
http://www.researchgate.net/institution/University_of_Sao_Paulo?enrichId=rgreq-49bfaf6b-7ec4-42cf-8a48-445cb5da46c5&enrichSource=Y292ZXJQYWdlOzI2NTg0NDI0ODtBUzoxNDMzMjE3MDM5MTU1MjBAMTQxMTE4MTk2NTkzMQ%3D%3D&el=1_x_6
http://www.researchgate.net/profile/Fatima_Caromano?enrichId=rgreq-49bfaf6b-7ec4-42cf-8a48-445cb5da46c5&enrichSource=Y292ZXJQYWdlOzI2NTg0NDI0ODtBUzoxNDMzMjE3MDM5MTU1MjBAMTQxMTE4MTk2NTkzMQ%3D%3D&el=1_x_7
Page 2: 12. NAC.runipar (1999) Características Da DMD
Page 3: 12. NAC.runipar (1999) Características Da DMD
Page 4: 12. NAC.runipar (1999) Características Da DMD
Page 5: 12. NAC.runipar (1999) Características Da DMD
Page 6: 12. NAC.runipar (1999) Características Da DMD
Page 7: 12. NAC.runipar (1999) Características Da DMD
Page 8: 12. NAC.runipar (1999) Características Da DMD
Page 9: 12. NAC.runipar (1999) Características Da DMD

Transporter-mediated disposition, clinical pharmacokinetics and cholestatic …dmd.aspetjournals.org/content/dmd/early/2017/04/24/dmd... · DMD # 74815 Transporter-mediated disposition,

Transporter-mediated disposition, clinical pharmacokinetics and cholestatic …dmd.aspetjournals.org/content/dmd/early/2017/04/24/dmd... · DMD # 74815 Transporter-mediated disposition,

DMD #26260dmd.aspetjournals.org/content/dmd/early/2009/12/07/dmd.108.0262… · DMD # 26260 3 ABSTRACT Evaluating biliary excretion, a major elimination pathway for many compounds,

DMD #26260dmd.aspetjournals.org/content/dmd/early/2009/12/07/dmd.108.0262… · DMD # 26260 3 ABSTRACT Evaluating biliary excretion, a major elimination pathway for many compounds,

Case study 2 Study 2 A...Benny Karmon DMD, Jerry Kohen DMD, Ariel Lor DMD, Yiftach Gratciany DMD, Zvi Laster DMD, Gideon Hallel DMD MPA, Tsvia Karmon A Retrospective Multi-Center Study

Case study 2 Study 2 A...Benny Karmon DMD, Jerry Kohen DMD, Ariel Lor DMD, Yiftach Gratciany DMD, Zvi Laster DMD, Gideon Hallel DMD MPA, Tsvia Karmon A Retrospective Multi-Center Study

Absorption and metabolism of Astragali Radix decoctiondmd.aspetjournals.org/content/dmd/early/2006/02/28/dmd.105.008300... · DMD #8300 2 Running title: Absorption and metabolism

Absorption and metabolism of Astragali Radix decoctiondmd.aspetjournals.org/content/dmd/early/2006/02/28/dmd.105.008300... · DMD #8300 2 Running title: Absorption and metabolism

Exposure-Efficacy Analysis of ... - dmd.aspetjournals.orgdmd.aspetjournals.org/content/dmd/early/2019/07/29/dmd.119.087023.full.pdf · DMD/2019/087023 1 Exposure-Efficacy Analysis

Exposure-Efficacy Analysis of ... - dmd.aspetjournals.orgdmd.aspetjournals.org/content/dmd/early/2019/07/29/dmd.119.087023.full.pdf · DMD/2019/087023 1 Exposure-Efficacy Analysis

Jay Wells, DMD

Jay Wells, DMD

Dmd Proiectwqwqq

Dmd Proiectwqwqq

Dmd Group West101009

Dmd Group West101009

DMD Nelson

DMD Nelson

DMD 2010 Program

DMD 2010 Program

Advances on DMD

Advances on DMD

APPLICATIONS Ford/Mercury 1999-2003 99-5803 · 2015. 7. 16. · Ford/Mercury 1999-2003 99-5803 • A) Alojamiento del radio • B) Rear support bracket CARACTERÍSTICAS DEL KIT COMPONENTES

APPLICATIONS Ford/Mercury 1999-2003 99-5803 · 2015. 7. 16. · Ford/Mercury 1999-2003 99-5803 • A) Alojamiento del radio • B) Rear support bracket CARACTERÍSTICAS DEL KIT COMPONENTES

Dmd Fg2010 Roprint

Dmd Fg2010 Roprint

DMD/2010/036616 Pharmacokinetic Optimization of 4 …dmd.aspetjournals.org/content/dmd/early/2011/07/08/dmd... · 2011-07-08 · DMD/2010/036616 2 Running title: DMPK of ABI compounds

DMD/2010/036616 Pharmacokinetic Optimization of 4 …dmd.aspetjournals.org/content/dmd/early/2011/07/08/dmd... · 2011-07-08 · DMD/2010/036616 2 Running title: DMPK of ABI compounds

DMD # 26393

DMD # 26393

Firm Profile - DMD

Firm Profile - DMD

DMD #52613 DMD Fast Forward. Published on June 11, 2013 …dmd.aspetjournals.org/content/dmd/early/2013/06/11/dmd... · Email: olivier.barbier@crchul.ulaval.ca ... deoxycholic acid;

DMD #52613 DMD Fast Forward. Published on June 11, 2013 …dmd.aspetjournals.org/content/dmd/early/2013/06/11/dmd... · Email: [email protected] ... deoxycholic acid;

Revised White Paper DMD June 21 2013dmd.aspetjournals.org/content/dmd/early/2013/06/21/dmd.113.052225... · (LJD); Pfizer, Pharmacokinetics, Dynamics, Drug Metabolism, Groton, CT

Revised White Paper DMD June 21 2013dmd.aspetjournals.org/content/dmd/early/2013/06/21/dmd.113.052225... · (LJD); Pfizer, Pharmacokinetics, Dynamics, Drug Metabolism, Groton, CT

DMD #2527R Glucuronidation of Nonsteroidal Anti ...dmd.aspetjournals.org/content/dmd/early/2005/04/20/dmd.104.002527... · DMD #2527R 6 studies represent a significant contribution

DMD #2527R Glucuronidation of Nonsteroidal Anti ...dmd.aspetjournals.org/content/dmd/early/2005/04/20/dmd.104.002527... · DMD #2527R 6 studies represent a significant contribution

Dmd Seminar Shptsk

Dmd Seminar Shptsk